Medical Polymer Market

Report Code CH 9017
Published in May, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Medical Polymer Market by type (Medical plastics, Medical elastomers), Application (Medical Disposables, Medical Instruments And Devices, Prosthetics, Diagnostics Instruments And Tools), Manufacturing Technology, and Region - Global Forecast to 2029

Overview

The global medical polymer market is valued at USD 41.1 billion in 2024 and is projected to reach USD 60.5 billion by 2029, growing at 8.0% cagr from 2024 to 2029. The surge in demand for medical polymers stems from the heightened focus on enhancing healthcare standards and safety protocols, spurring the creation of cutting-edge medical tools and apparatus. Furthermore, advancements in polymer technology have broadened the scope and utility of medical polymers, prompting their integration into diverse medical domains. This escalating demand is further propelled by the necessity for materials that ensure biocompatibility, resilience, and straightforward sterilization procedures in medical environments. Attractive Opportunities in the Medical Po

Attractive Opportunities in the Medical Polymer Market

ASIA-PACIFIC

The market in Asia Pacific is expected to witness high growth during the forecast period due to the increasing investments in the healthcare infrastructure.

The market growth is attributed to the growing aging population globally and increasing demand for biocompatible materials.

The European medical polymer market is expected to be worth USD 14.7 billion by 2029, growing at CAGR of 6.2% during the forecast period.

Growth in regenerative medicine and demand for minimally invasive devices are the factors expected to provide lucrative opportunities for market players.

Cost constraints for novel materials to pose a challenge to the growth of this market.

Global Medical Polymer Market Dynamics

Driver: Increasing demand for biocompatible materials

The increasing demand for biocompatible materials is a pivotal driver propelling the growth of the medical polymer market. Biocompatible materials refer to substances that are compatible with living tissues and organisms without causing adverse reactions such as inflammation or rejection. In the healthcare sector, the demand for biocompatible materials stems from their critical role in medical devices, implants, and drug delivery systems. Patients and healthcare providers alike prioritize materials that seamlessly integrate with the body, minimizing the risk of complications and enhancing treatment outcomes. One of the key factors driving this demand is the rising prevalence of chronic diseases and age-related conditions globally. As the incidence of conditions such as cardiovascular diseases, orthopedic disorders, and diabetes continues to increase, there is a growing need for medical devices and implants made from materials that are not only durable and functional but also compatible with biological systems. Biocompatible polymers such as polyethylene glycol (PEG), polylactic acid (PLA), and polyvinyl alcohol (PVA) have gained traction due to their biodegradability, low toxicity, and ability to mimic natural tissues. Moreover, advancements in material science and polymer engineering have led to the development of innovative biocompatible polymers with tailored properties, including enhanced mechanical strength, controlled degradation rates, and improved biocompatibility profiles. These materials play a crucial role in areas such as tissue engineering, regenerative medicine, and minimally invasive surgeries, driving the adoption of biocompatible polymers across diverse medical applications. As healthcare technologies continue to evolve, the demand for biocompatible materials is expected to remain strong, creating opportunities for market players to innovate and meet the evolving needs of the healthcare industry.

Restraint: Environmental sustainability concerns

Environmental sustainability concerns pose a significant restraint in the medical polymer market, impacting the entire lifecycle of polymer-based medical products from production to disposal. The growing emphasis on environmental stewardship, resource conservation, and waste reduction has prompted increased scrutiny of the environmental footprint associated with medical polymers. Key areas of concern include raw material sourcing, manufacturing processes, product design, packaging, and end-of-life disposal or recycling. One of the primary challenges related to environmental sustainability is the reliance on petrochemical-derived polymers, such as polyethylene, polypropylene, and PVC, which are non-biodegradable and contribute to plastic pollution. The extraction and processing of fossil fuel-based feedstocks raises concerns about carbon emissions, energy consumption, and environmental impact. Additionally, the disposal of medical devices and packaging made from these polymers can lead to landfill accumulation and environmental degradation if not managed responsibly. Furthermore, the use of certain additives, fillers, and processing aids in medical polymers, such as plasticizers, flame retardants, and antimicrobial agents, raises questions about their potential environmental toxicity and persistence in ecosystems. Regulatory restrictions on hazardous substances, such as REACH regulations in Europe or FDA guidelines in the United States, add complexity to material selection and product development in the medical polymer industry. Moreover, the lack of standardized recycling infrastructure and limited options for recycling medical polymers further exacerbate environmental concerns. While initiatives to promote recycling and circular economy principles are emerging, challenges remain in establishing efficient collection, sorting, and processing systems for medical plastic waste. Addressing environmental sustainability concerns requires collaboration among stakeholders, including manufacturers, regulators, healthcare providers, and consumers. Strategies such as using bio-based polymers, implementing eco-friendly manufacturing processes, designing recyclable or biodegradable products, and adopting closed-loop recycling systems are critical to mitigating environmental impacts and ensuring long-term sustainability in the medical polymer market.

 

Opportunities: Demand for minimally invasive devices

The rise of minimally invasive devices presents a significant opportunity in the medical polymer market, driving demand for specialized materials that enable the development of innovative medical technologies and procedures. Minimally invasive procedures involve accessing and treating internal organs or structures through small incisions or natural body openings, reducing patient trauma, recovery time, and healthcare costs compared to traditional surgical approaches. Medical polymers play a crucial role in the fabrication of minimally invasive devices, providing properties such as flexibility, biocompatibility, and precision engineering that are essential for their functionality and performance. One of the key advantages of medical polymers in minimally invasive devices is their ability to be molded into complex shapes, miniaturized components, and catheter-based systems that navigate through narrow anatomical pathways. Polymers such as polyurethane, polyethylene, and PEEK (polyether ether ketone) are commonly used in catheters, guidewires, stents, and endoscopic tools, offering low friction, high strength, and compatibility with medical imaging techniques. Moreover, advancements in polymer processing technologies, such as extrusion, injection molding, and additive manufacturing (3D printing), enable the customization and production of minimally invasive devices with precise dimensions, surface textures, and functionalities. These manufacturing capabilities facilitate rapid prototyping, iteration, and scale-up of device designs, accelerating time-to-market and innovation cycles. The expanding applications of medical polymers in minimally invasive devices include cardiovascular interventions, endoscopy procedures, laparoscopic surgeries, and neurovascular interventions. Collaboration between medical device manufacturers, polymer suppliers, and healthcare providers drives product development and adoption, fostering a dynamic ecosystem of technological advancements and clinical outcomes. Furthermore, the growing trend towards outpatient procedures, ambulatory care, and remote monitoring systems creates opportunities for miniaturized, implantable, and wearable devices made from biocompatible and bioresorbable polymers. As healthcare systems prioritize patient-centric care, cost-effectiveness, and improved clinical outcomes, the demand for medical polymers in minimally invasive devices is expected to continue growing, shaping the future of healthcare delivery and medical innovations.

Challenges: Long term durability and degradation control

Long-term durability and degradation control present significant challenges in the medical polymer market, impacting the performance, reliability, and safety of medical devices and implants over time. Medical polymers are designed to withstand physiological conditions, mechanical stresses, and environmental factors while maintaining their structural integrity, biocompatibility, and functionality throughout their intended lifespan. However, ensuring long-term durability and degradation control poses several complex challenges that require careful material selection, design optimization, and regulatory compliance. One of the key challenges related to long-term durability is predicting and controlling the degradation kinetics of biodegradable polymers used in implantable devices or drug delivery systems. Biodegradable polymers such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and their copolymers (PLGA) are susceptible to hydrolytic and enzymatic degradation processes in vivo, leading to changes in mechanical properties, degradation rates, and degradation byproducts. Balancing degradation rates with tissue integration and therapeutic release profiles is essential to ensure optimal performance and safety of biodegradable medical polymers. Moreover, achieving long-term durability requires comprehensive testing, validation, and post-market surveillance to assess material stability, degradation behavior, and biocompatibility over extended periods. Accelerated aging studies, biocompatibility testing according to ISO 10993 standards, and real-world clinical evaluations are essential to evaluate the long-term performance and safety of medical polymers in clinical use. Additionally, the control of degradation products and their potential impact on surrounding tissues, immune responses, and inflammatory reactions is a critical consideration in medical polymer design. Minimizing the formation of acidic byproducts, cytotoxic compounds, or inflammatory responses during polymer degradation is essential to prevent adverse effects and ensure patient safety. Furthermore, regulatory requirements for long-term durability and degradation control add complexity to product development and market approval processes. Demonstrating compliance with regulatory standards such as ISO 10993, FDA guidance documents, and international guidelines requires robust scientific evidence, documentation, and risk assessment strategies. Furthermore, regulatory requirements for long-term durability and degradation control add complexity to product development and market approval processes. Demonstrating compliance with regulatory standards such as ISO 10993, FDA guidance documents, and international guidelines requires robust scientific evidence, documentation, and risk assessment strategies.

Global Medical Polymer Market Ecosystem Analysis

Prominent companies in this market include well-established, financially stable manufacturers of centrifuges. These companies have been operating in the market for several years and possess a diversified product portfolio and strong global sales and marketing networks. Prominent companies in this market include BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese Corporation (US), Evonik Industries (Germany).

 

Based on type, medical plastics is the fastest growing type segment in medical polymer market.

Medical plastics are experiencing rapid growth as the fastest-growing type segment in the medical polymer market for several compelling reasons. Firstly, the versatility and adaptability of medical plastics make them essential in a wide range of medical applications, from disposable syringes to advanced surgical equipment. Their properties such as biocompatibility, durability, and ease of processing meet the stringent requirements of the healthcare industry. Additionally, the shift towards single-use medical products and the increasing demand for minimally invasive procedures are driving the adoption of medical plastics. Moreover, ongoing advancements in polymer technology, including the development of bio-based and sustainable plastics, further contribute to the significant growth of medical plastics in the medical polymer market.

Based on application, medical instruments and devices is the fastest growing application in the medical polymer market.

The medical instruments and devices segment is experiencing rapid growth as the fastest-growing application in the medical polymer market due to several key factors. Firstly, the rising demand for advanced medical technologies and the increasing prevalence of chronic diseases are driving the need for innovative medical devices and instruments. These devices require materials with specific properties like biocompatibility, sterilizability, and chemical resistance, all of which medical polymers can provide. Additionally, the trend towards minimally invasive procedures is driving the development of lightweight and durable medical devices, further boosting the demand for medical polymers in this segment. Furthermore, ongoing technological advancements in medical polymer formulations and manufacturing processes are enhancing the performance and reliability of medical instruments and devices, reinforcing their rapid growth in the market.

ASIA-PACIFC region holds the largest share of the Medical Polymer Market.

The Asia Pacific region emerges as the fastest-growing region in the medical polymer market due to several key factors. Firstly, the region's rapid economic development and increasing healthcare expenditure are driving the demand for advanced medical devices and equipment, which heavily rely on medical polymers. Moreover, the region benefits from a large and aging population, leading to a higher prevalence of chronic diseases and the need for medical interventions. Additionally, favorable government initiatives, investments in healthcare infrastructure, and a robust manufacturing ecosystem contribute to the region's growth. Furthermore, the shift towards personalized medicine and the adoption of innovative medical technologies further propel market expansion in the Asia Pacific region, positioning it as a dynamic and lucrative market for medical polymers.

 
 

Recent Developments of Medical Polymer Market industry

  • In March 2024, SABIC, a global leader in the chemical industry, has successfully demonstrated the feasibility of recycling used medical plastic back into the medical materials stream with the dialysis department at Jessa Hospital, one of the largest non-university medical clusters in the Limburg region of Flanders, Belgium. Serving as a pilot proof-of-concept, used medical plastic generated at Jessa’s hospitals was converted to pyrolysis oil in an advanced recycling process, delivering circular feedstock for SABIC’s production of TRUCIRCLE polymers in medical grade quality with same performance, purity, and physiological safety as virgin-based medical grade polymers. In October 2023, Covestro has expanded its production capacities for thermoplastic polyurethane (TPU) films in the Platilon range, as well as the associated infrastructure and logistics in Bomlitz, Lower Saxony, Germany. These thermoplastic polyurethane (TPU) films are highly utilized in medical polymers market. In July 2021, Celanese Corporation a global chemical and specialty materials company has announced an expansion of its Florence, Kentucky research and development center with the addition of a Pharmaceutical Drug Delivery Feasibility Lab. The new feasibility lab will drive new development for long-acting controlled release drug delivery.
  • In October 2023, Covestro has commenced operations at its first dedicated mechanical recycling (MCR) compounding line for polycarbonates at its integrated site in Shanghai, China. This line is set to produce over 25,000 tons of premium-quality polycarbonates and blends containing mechanically recycled materials annually, in response to the growing demand for post-consumer-recycled (PCR) plastics, particularly in applications within the electrical and electronic products, automotive, healthcare, and consumer goods sectors. In September 2021, BASF SE has made a strategic partnership with Sanyo Chemical Industries Ltd. for the development of polyurethane dispersions (PUD)s, which are highly utilized in medical polymers market. The two parties aim to jointly develop and produce innovative products with strong sustainability contribution. Newly developed technologies and products will have worldwide market access through the two companies global production.

Key Market Players

Want to explore hidden markets that can drive new revenue in Medical Polymer Market?

Scope of the Report

Report Attribute Details
Years considered for the study 2020-2029
Base Year 2023
Forecast period 2024–2029
Units considered Value (USD Million), Volume (Kiloton)
Segments Type, Application, Manufacturing Technology, and Region
Regions Asia Pacific, North America, Europe, Middle East & Africa, and South America
Companies BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), DuPont (US)

 

Key Questions Addressed by the Report

What are the factors influencing the growth of the medical polymer market?
The growth of the medical polymer market is influenced by factors such as the increasing demand for minimally invasive surgical procedures, technological advancements in medical devices, the rise in chronic diseases, and the expanding geriatric population requiring healthcare.
Which are the key applications driving the medical polymer market?
The key applications driving the demand for medical polymers are medical disposables, prosthetics, medical instruments and devices, and others.
Who are the major manufacturers?
Major manufacturers include BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese Corporation (US), and Evonik Industries (Germany).
What will be the growth prospects of the medical polymer market?
The medical polymer market is expected to witness robust growth due to rising healthcare needs globally, advancements in polymer technology for medical applications, increasing demand for biocompatible materials, and expanding applications in areas like drug delivery systems and implants.
What will be the growth prospects of the medical polymer market in terms of CAGR in the next five years?
The CAGR of the market is projected to be between 8% and 9% over the next five years.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Medical Polymer Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
27
RESEARCH METHODOLOGY
31
EXECUTIVE SUMMARY
40
PREMIUM INSIGHTS
43
MARKET OVERVIEW
46
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing demand for biocompatible materials
    - Growing aging population globally
    - Advancements in medical technology
    - Regulatory support for medical-grade materials
    RESTRAINTS
    - Regulatory complexities and approvals
    - High competition from alternative materials
    - Environmental sustainability concerns
    OPPORTUNITIES
    - Growth in regenerative medicine
    - Demand for minimally invasive devices
    - Advancements in biodegradable polymers
    CHALLENGES
    - Cost constraints for novel materials
    - Long-term durability and degradation control
  • 5.3 PORTER’S FIVE FORCES ANALYSIS
    THREAT FROM NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 MACROECONOMIC INDICATORS
    GLOBAL GDP TRENDS
INDUSTRY TRENDS
57
  • 6.1 INTRODUCTION
  • 6.2 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 6.3 VALUE CHAIN ANALYSIS
    RAW MATERIAL
    MANUFACTURER
    DISTRIBUTION
    END USER
  • 6.4 ECOSYSTEM ANALYSIS
  • 6.5 CASE STUDY ANALYSIS
    EVONIK INDUSTRIES PROVIDES MEDICAL POLYMERS TO JENACELL GMBH FOR WOUND DRESSINGS, IMPLANTABLE MATERIALS, AND DRUG DELIVERY SYSTEMS
    ENSINGER OFFERS HIGH-PERFORMANCE, MEDICAL-GRADE POLYMERS FOR HIGH-FREQUENCY SURGERY
  • 6.6 REGULATORY LANDSCAPE
  • 6.7 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGY
    COMPLEMENTARY TECHNOLOGY
    ADJACENT TECHNOLOGY
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
    REVENUE SHIFT AND NEW REVENUE POCKETS FOR MEDICAL POLYMER MANUFACTURERS
  • 6.9 TRADE ANALYSIS
    IMPORT SCENARIO
    EXPORT SCENARIO
  • 6.10 KEY CONFERENCES & EVENTS
  • 6.11 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND, BY REGION
    AVERAGE SELLING PRICE TREND, BY APPLICATION
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
  • 6.12 INVESTMENT AND FUNDING SCENARIO
  • 6.13 PATENT ANALYSIS
    METHODOLOGY
    PATENTS GRANTED WORLDWIDE, 2013–2023
    PATENT PUBLICATION TRENDS
    INSIGHTS
    LEGAL STATUS OF PATENTS
    JURISDICTION-WISE PATENT ANALYSIS
    TOP COMPANIES/APPLICANTS
    TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS
MEDICAL POLYMER MARKET, BY TYPE
77
  • 7.1 INTRODUCTION
  • 7.2 MEDICAL PLASTICS
    ADVANCEMENTS IN MATERIAL SCIENCE AND MANUFACTURING TECHNOLOGIES TO DRIVE MARKET
    POLYPROPYLENE (PP)
    POLYVINYL CHLORIDE (PVC)
    POLYETHYLENE (PE)
    POLYSTYRENE (PS)
    ENGINEERING & HIGH-PERFORMANCE PLASTICS
    - Polyether ether ketone (PEEK)
    - Nylon/polyamide (PA)
    - Polyphenulsulfone (PPSU)
    - Polysulfones (PSU)
    - Polymethyl methacrylate (PMMA)
    - Polycarbonate (PC)
    - Acrylonitrile butadiene styrene (ABS)
    - Other engineering & high-performance plastics
    OTHER MEDICAL PLASTICS
  • 7.3 MEDICAL ELASTOMERS
    FLEXIBILITY, DURABILITY, AND BIOCOMPATIBILITY TO DRIVE MARKET
    SILICONE
    THERMOPLASTIC ELASTOMERS
    - Thermoplastic polyurethane (TPU)
    - Thermoplastic vulcanizates (TPV)
    - Thermoplastic styrenic elastomers (TPS)
    - Thermoplastic copolyester elastomers (TPC-ET)
  • 7.4 OTHER MEDICAL ELASTOMERS
MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY
87
  • 8.1 INTRODUCTION
  • 8.2 EXTRUSION TUBING
    INCREASING USE IN INTRAVENOUS DELIVERY SYSTEMS, CATHETERS, AND SURGICAL INSTRUMENTS TO DRIVE MARKET
  • 8.3 COMPRESSION MOLDING
    INCREASING USE IN PROSTHETICS, ORTHOPEDIC IMPLANTS, AND DENTAL COMPONENTS TO DRIVE MARKET
  • 8.4 INJECTION MOLDING
    INCREASING USE OF SYRINGES, SURGICAL INSTRUMENTS, AND IMPLANTABLE DEVICES TO DRIVE MARKET
  • 8.5 OTHER MANUFACTURING TECHNOLOGIES
MEDICAL POLYMER MARKET, BY APPLICATION
92
  • 9.1 INTRODUCTION
  • 9.2 MEDICAL DISPOSABLES
    INCREASING DEMAND FOR CATHETERS AND SYRINGES TO DRIVE MARKET
    GLOVES
    SYRINGES
    MEDICAL BAGS
    OTHER MEDICAL DISPOSABLES
  • 9.3 MEDICAL INSTRUMENTS & DEVICES
    INCREASING SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET
    MEDICAL TUBES
    CATHETERS
    DRUG DELIVERY
    OTHER MEDICAL INSTRUMENTS & DEVICES
  • 9.4 PROSTHETICS
    TECHNOLOGICAL DEVELOPMENTS TO DRIVE DEMAND
    IMPLANTS
    LIMB PROSTHESIS
    OTHER PROSTHETICS APPLICATIONS
  • 9.5 DIAGNOSTIC INSTRUMENTS & TOOLS
    INCREASING DEMAND IN SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET
    DENTAL TOOLS
    SURGICAL INSTRUMENTS
    OTHER DIAGNOSTIC INSTRUMENTS & TOOLS
  • 9.6 OTHER APPLICATIONS
MEDICAL POLYMER MARKET, BY REGION
105
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    IMPACT OF RECESSION ON NORTH AMERICA
    US
    - High R&D investments in medical sector to drive market growth
    CANADA
    - Emerging demand for dental implants to drive market
    MEXICO
    - Rising focus of manufacturers to expand manufacturing facilities to drive market growth
  • 10.3 ASIA PACIFIC
    RECESSION IMPACT
    CHINA
    - Largest market for medical polymers in Asia Pacific
    INDIA
    - Rapid economic growth and growing population to drive market growth
    SOUTH KOREA
    - Advanced healthcare and medical technologies to propel market growth
    JAPAN
    - Developments in minimally invasive treatment and robotic surgery to support market growth
    AUSTRALIA
    - Regulatory compliance and strategic collaborations to support market growth
    REST OF ASIA PACIFIC
  • 10.4 EUROPE
    RECESSION IMPACT
    GERMANY
    - Rising demand in dental implant application to drive market
    FRANCE
    - Aging population and sedentary lifestyle to drive demand
    UK
    - Growing incidences of chronic diseases and government support for innovation to drive market
    ITALY
    - Strong production facilities with presence of global players to propel market growth
    SPAIN
    - Increase in government funding for healthcare sector to support market
    REST OF EUROPE
  • 10.5 MIDDLE EAST & AFRICA
    RECESSION IMPACT
    SAUDI ARABIA
    - Growing population and rise in aging population to drive market
    UAE
    - Population growth and changing epidemiology expected to drive market growth
    SOUTH AFRICA
    - NHI scheme, increased government spending on healthcare, and priority programs to propel market
    REST OF MIDDLE EAST & AFRICA
  • 10.6 SOUTH AMERICA
    RECESSION IMPACT
    BRAZIL
    - Growing aging population, expanding economy, and increasing health awareness to drive market
    ARGENTINA
    - Availability of highly trained specialists and low cost of medical services boosting medical tourism industry
    REST OF SOUTH AMERICA
COMPETITIVE LANDSCAPE
343
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES
  • 11.3 MARKET SHARE ANALYSIS
    RANKING OF KEY MARKET PLAYERS, 2023
    MARKET SHARE ANALYSIS OF KEY PLAYERS
    - BASF SE
    - SABIC
    - Covestro AG
    - Celanese Corporation
    - Evonik Industries
  • 11.4 REVENUE ANALYSIS
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.6 BRAND/PRODUCT COMPARISON
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT
    - Company overall footprint
    - Company type footprint
    - Company application footprint
    - Company region footprint
  • 11.8 COMPANY EVALUATION MATRIX: START-UPS AND SMES
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
  • 11.9 COMPETITIVE SCENARIO AND TRENDS
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
366
  • 12.1 MAJOR PLAYERS
    BASF SE
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    SABIC
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    COVESTRO AG
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    CELANESE CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    EVONIK INDUSTRIES
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    ARKEMA
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    SOLVAY
    - Business overview
    - Products/Services/Solutions offered
    - MnM view
    KURARAY CO., LTD.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    MOMENTIVE PERFORMANCE MATERIALS INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    DUPONT
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
  • 12.2 OTHER PLAYERS
    TRINSEO
    KRATON CORPORATION
    TOTAL PLASTICS
    SIMONA AMERICA
    DSM
    INVIBIO
    AVIENT CORPORATION
    RTP COMPANY
    TEKNIPLEX
    TEKNOR APEX
    MITSUBISHI CHEMICALS ADVANCED MATERIALS
    WACKER CHIMIE
    HARDIE POLYMERS
    ELIX POLYMERS
    INNOVATIVE POLYMER COMPOUNDS
APPENDIX
420
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 MEDICAL POLYMER MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 MEDICAL POLYMER MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 3 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2018–2025
  • TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS
  • TABLE 5 KEY BUYING CRITERIA IN MAJOR APPLICATIONS
  • TABLE 6 MEDICAL POLYMER MARKET: ROLE IN ECOSYSTEM
  • TABLE 7 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 MEDICAL POLYMER MARKET: CONFERENCES & EVENTS, 2024−2025
  • TABLE 12 TOTAL NUMBER OF PATENTS
  • TABLE 13 TOP TEN PATENT OWNERS
  • TABLE 14 MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 15 MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 16 MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 17 MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 18 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION)
  • TABLE 19 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 20 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON)
  • TABLE 21 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON)
  • TABLE 22 MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 23 MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 24 MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 25 MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 26 MEDICAL POLYMER MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 27 MEDICAL POLYMER MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 28 MEDICAL POLYMER MARKET, BY REGION, 2020–2023 (KILOTON)
  • TABLE 29 MEDICAL POLYMER MARKET, BY REGION, 2024–2029 (KILOTON)
  • TABLE 30 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 31 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 32 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (KILOTON)
  • TABLE 33 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (KILOTON)
  • TABLE 34 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 35 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 36 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 37 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 38 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 39 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 41 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 42 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION)
  • TABLE 43 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON)
  • TABLE 45 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON)
  • TABLE 46 US: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 47 US: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 48 US: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 49 US: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 50 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 51 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 52 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 53 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 54 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 55 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 56 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 57 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 58 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 59 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 60 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 61 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 62 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 63 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 64 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 65 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 66 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 67 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 68 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 69 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 70 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (KILOTON)
  • TABLE 73 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (KILOTON)
  • TABLE 74 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 76 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 77 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 78 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 81 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 82 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON)
  • TABLE 85 ASIA PACIFIC, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON)
  • TABLE 86 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 87 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 88 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 89 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 90 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 91 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 92 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 93 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 94 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 95 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 96 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 97 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 98 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 99 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 100 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 101 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 102 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 103 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 104 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 105 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 106 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 107 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 108 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 109 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 110 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 111 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 112 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 113 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 114 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 115 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 116 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 117 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 118 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 119 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 120 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 121 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 122 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 123 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 124 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 125 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 126 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 127 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 128 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 129 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 130 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 131 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 132 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 133 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 134 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 135 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 136 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (KILOTON)
  • TABLE 137 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (KILOTON)
  • TABLE 138 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 139 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 140 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 141 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 142 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 143 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 144 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 145 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 146 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION)
  • TABLE 147 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 148 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON)
  • TABLE 149 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON)
  • TABLE 150 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 151 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 152 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 153 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 154 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 155 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 156 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 157 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 158 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 159 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 160 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 161 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 162 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 163 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 164 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 165 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 166 UK: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 167 UK: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 168 UK: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 169 UK: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 170 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 171 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 172 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 173 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 174 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 175 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 176 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 177 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 178 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 179 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 180 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 181 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 182 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 183 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 184 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 185 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 186 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 187 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 188 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 189 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 190 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 191 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 192 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 193 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 194 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 195 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 196 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 197 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 198 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 199 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 200 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (KILOTON)
  • TABLE 201 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (KILOTON)
  • TABLE 202 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 203 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 204 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 205 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 206 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 207 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 208 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 209 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 210 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION)
  • TABLE 211 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 212 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON)
  • TABLE 213 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON)
  • TABLE 214 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 215 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 216 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 217 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 218 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 219 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 220 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 221 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 222 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 223 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 224 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 225 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 226 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 227 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 228 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 229 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 230 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 231 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 232 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 233 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 234 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 235 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 236 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 237 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 238 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 239 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 240 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 241 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 242 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 243 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 244 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 245 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 246 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 247 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 248 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (KILOTON)
  • TABLE 249 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (KILOTON)
  • TABLE 250 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 251 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 252 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 253 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 254 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 255 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 256 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 257 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 258 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION)
  • TABLE 259 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION)
  • TABLE 260 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON)
  • TABLE 261 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON)
  • TABLE 262 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 263 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 264 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 265 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 266 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 267 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 268 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 269 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 270 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 271 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 272 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 273 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 274 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 275 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 276 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 277 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 278 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 279 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 280 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON)
  • TABLE 281 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 282 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 283 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 284 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON)
  • TABLE 285 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 286 MEDICAL POLYMER MARKET: DEGREE OF COMPETITION
  • TABLE 287 MEDICAL POLYMER MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 288 MEDICAL POLYMER MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • TABLE 289 MEDICAL POLYMER MARKET: PRODUCT LAUNCHES, NOVEMBER 2021−MARCH 2024
  • TABLE 290 MEDICAL POLYMER MARKET: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 291 MEDICAL POLYMER MARKET: EXPANSIONS, JANUARY 2021–MARCH 2024
  • TABLE 292 BASF SE: COMPANY OVERVIEW
  • TABLE 293 BASF SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 294 BASF SE: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 295 SABIC: COMPANY OVERVIEW
  • TABLE 296 SABIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 297 SABIC: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 298 COVESTRO AG: COMPANY OVERVIEW
  • TABLE 299 COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 300 COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
  • TABLE 301 COVESTRO AG: EXPANSIONS, JANUARY 2021–MARCH 2024
  • TABLE 302 CELANESE CORPORATION: COMPANY OVERVIEW
  • TABLE 303 CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 304 CELANESE CORPORATION: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 305 CELANESE CORPORATION: EXPANSIONS, JANUARY 2021–MARCH 2024
  • TABLE 306 EVONIK INDUSTRIES: COMPANY OVERVIEW
  • TABLE 307 EVONIK INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 308 EVONIK INDUSTRIES: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
  • TABLE 309 EVONIK INDUSTRIES: EXPANSIONS, JANUARY 2021–MARCH 2024
  • TABLE 310 ARKEMA: COMPANY OVERVIEW
  • TABLE 311 ARKEMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 312 ARKEMA: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
  • TABLE 313 ARKEMA: EXPANSIONS, JANUARY 2021–MARCH 2024
  • TABLE 314 SOLVAY: COMPANY OVERVIEW
  • TABLE 315 SOLVAY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 316 KURARAY CO., LTD.: COMPANY OVERVIEW
  • TABLE 317 KURARAY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 318 KURARAY CO., LTD.: EXPANSIONS, JANUARY 2021–MARCH 2024
  • TABLE 319 MOMENTIVE PERFORMANCE MATERIALS INC.: COMPANY OVERVIEW
  • TABLE 320 MOMENTIVE PERFORMANCE MATERIALS INC.: PRODUCTS/SERVICES/ SOLUTIONS OFFERED
  • TABLE 321 MOMENTIVE PERFORMANCE MATERIALS INC.: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 322 MOMENTIVE PERFORMANCE MATERIALS INC.: EXPANSIONS, JANUARY 2021–MARCH 2024
  • TABLE 323 DUPONT: COMPANY OVERVIEW
  • TABLE 324 DUPONT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 325 DUPONT: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 326 DUPONT: EXPANSIONS, JANUARY 2021–MARCH 2024
  • TABLE 327 TRINSEO: COMPANY OVERVIEW
  • TABLE 328 KRATON CORPORATION: COMPANY OVERVIEW
  • TABLE 329 TOTAL PLASTICS: COMPANY OVERVIEW
  • TABLE 330 SIMONA AMERICA: COMPANY OVERVIEW
  • TABLE 331 DSM: COMPANY OVERVIEW
  • TABLE 332 INVIBIO: COMPANY OVERVIEW
  • TABLE 333 AVIENT CORPORATION: COMPANY OVERVIEW
  • TABLE 334 RTP COMPANY: COMPANY OVERVIEW
  • TABLE 335 TEKNIPLEX: COMPANY OVERVIEW
  • TABLE 336 TEKNOR APEX: COMPANY OVERVIEW
  • TABLE 337 MITSUBISHI CHEMICALS ADVANCED MATERIALS: COMPANY OVERVIEW
  • TABLE 338 WACKER CHIMIE: COMPANY OVERVIEW
  • TABLE 339 HARDIE POLYMERS: COMPANY OVERVIEW
  • TABLE 340 ELIX POLYMERS: COMPANY OVERVIEW
  • TABLE 341 INNOVATIVE POLYMER COMPOUNDS: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 MEDICAL POLYMER MARKET SEGMENTATION
  • FIGURE 2 MEDICAL POLYMER MARKET: RESEARCH DESIGN
  • FIGURE 3 MARKET SIZE ESTIMATION APPROACH: DEMAND SIDE
  • FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 6 MEDICAL POLYMER MARKET: DATA TRIANGULATION
  • FIGURE 7 MEDICAL PLASTICS SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 8 MEDICAL INSTRUMENTS & DEVICES TO BE FASTEST-GROWING APPLICATION DURING FORECAST PERIOD
  • FIGURE 9 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
  • FIGURE 10 INCREASING DEMAND FROM MEDICAL INSTRUMENTS & DEVICES APPLICATION TO DRIVE MARKET DURING FORECAST PERIOD
  • FIGURE 11 MEDICAL PLASTICS SEGMENT TO LEAD MEDICAL POLYMER MARKET DURING FORECAST PERIOD
  • FIGURE 12 MEDICAL INSTRUMENTS & DEVICES SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 13 EXTRUSION TUBING SEGMENT TO ACCOUNT FOR LARGEST SHARE OF MEDICAL POLYMER MARKET
  • FIGURE 14 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 15 MEDICAL POLYMER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16 PORTER’S FIVE FORCES ANALYSIS: MEDICAL POLYMER MARKET
  • FIGURE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS
  • FIGURE 18 KEY BUYING CRITERIA IN MAJOR APPLICATIONS
  • FIGURE 19 MEDICAL POLYMER MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 20 MEDICAL POLYMER MARKET: ECOSYSTEM MAPPING
  • FIGURE 21 REVENUE SHIFT IN MEDICAL POLYMER MARKET
  • FIGURE 22 IMPORT OF MEDICAL POLYMERS, BY COUNTRY, 2019–2022 (USD THOUSAND)
  • FIGURE 23 EXPORT OF MEDICAL POLYMERS, BY COUNTRY, 2019–2022 (USD THOUSAND)
  • FIGURE 24 AVERAGE SELLING PRICE TREND, BY REGION (USD/KILOTON)
  • FIGURE 25 AVERAGE SELLING PRICE TREND, BY APPLICATION (USD/KILOTON)
  • FIGURE 26 AVERAGE SELLING PRICE, BY KEY MARKET PLAYERS (USD/ KILOTON)
  • FIGURE 27 INVESTMENT AND FUNDING SCENARIO, 2019−2023 (USD MILLION)
  • FIGURE 28 TOTAL NUMBER OF PATENTS PUBLISHED FROM 2013 TO 2023
  • FIGURE 29 PATENT ANALYSIS, BY LEGAL STATUS
  • FIGURE 30 TOP JURISDICTIONS FOR MEDICAL POLYMER PATENTS
  • FIGURE 31 TOP 10 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENTS
  • FIGURE 32 MEDICAL PLASTICS TO LEAD OVERALL MARKET DURING FORECAST PERIOD
  • FIGURE 33 EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 34 MEDICAL INSTRUMENTS & DEVICES TO BE LARGEST APPLICATION OF MEDICAL POLYMER
  • FIGURE 35 MEDICAL POLYMER MARKET SNAPSHOT
  • FIGURE 36 NORTH AMERICA: MEDICAL POLYMER MARKET SNAPSHOT
  • FIGURE 37 ASIA PACIFIC: MEDICAL POLYMER MARKET SNAPSHOT
  • FIGURE 38 EUROPE: MEDICAL POLYMER MARKET SNAPSHOT
  • FIGURE 39 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL POLYMER MARKET BETWEEN 2021 AND 2024
  • FIGURE 40 RANKING OF TOP FIVE PLAYERS IN MEDICAL POLYMER MARKET, 2023
  • FIGURE 41 MEDICAL POLYMER MARKET: SHARE OF KEY PLAYERS
  • FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2021–2024
  • FIGURE 43 COMPANY VALUATION OF LEADING COMPANIES IN MEDICAL POLYMER MARKET, 2023
  • FIGURE 44 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL POLYMER MARKET, 2023
  • FIGURE 45 MEDICAL POLYMER MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 46 MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX, 2023
  • FIGURE 47 MEDICAL POLYMER MARKET: START-UPS/SMES EVALUATION MATRIX, 2023
  • FIGURE 48 BASF SE: COMPANY SNAPSHOT
  • FIGURE 49 SABIC: COMPANY SNAPSHOT
  • FIGURE 50 COVESTRO AG: COMPANY SNAPSHOT
  • FIGURE 51 CELANESE CORPORATION: COMPANY SNAPSHOT
  • FIGURE 52 EVONIK INDUSTRIES: COMPANY SNAPSHOT
  • FIGURE 53 ARKEMA: COMPANY SNAPSHOT
  • FIGURE 54 SOLVAY: COMPANY SNAPSHOT
  • FIGURE 55 KURARAY CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 56 DUPONT: COMPANY SNAPSHOT

The study involved four major activities in estimating the market size of the medical polymer market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources have been referred to for identifying and collecting information for this study. These secondary sources include annual reports, press releases, investor presentations of companies, white papers, certified publications, trade directories, certified publications, articles from recognized authors, gold standard and silver standard websites, and databases.

Secondary research has been used to obtain key information about the value chain of the industry, monetary chain of the market, the total pool of key medical polymer, market classification and segmentation according to industry trends to the bottom-most level, and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

The medical polymer market comprises several stakeholders in the value chain, which include raw material suppliers, manufacturers, and end users. Various primary sources from the supply and demand sides of the medical polymer market have been interviewed to obtain qualitative and quantitative information. The primary interviewees from the demand side include key opinion leaders in end-use sectors. The primary sources from the supply side include manufacturers, associations, and institutions involved in the medical polymer industry.

Primary interviews were conducted to gather insights such as market statistics, data of revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to type, application, manufacturing technology, and region. Stakeholders from the demand side, such as CIOs, CTOs, and CSOs were interviewed to understand the buyer’s perspective on the suppliers, products, component providers, and their current usage of medical polymer and future outlook of their business which will affect the overall market.

The breakdown of profiles of the primary interviewees is illustrated in the figure below:

Medical  Polymer Market Size, and Share

Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2023 available in the public domain, product portfolios, and geographical presence.

Other designations include sales representatives, production heads, and technicians.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down approach was used to estimate and validate the size of various submarkets for medical polymer for each region. The research methodology used to estimate the market size included the following steps:

  • The key players in the industry have been identified through extensive secondary research.
  • The supply chain of the industry has been determined through primary and secondary research.
  • The global market was then segmented into five major regions and validated by industry experts.
  • All percentage shares, splits, and breakdowns based on type, application, manufacturing technology, and country were determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and analysis and presented in this report.

Medical Polymer Market: Bottum-Up Approach

Medical  Polymer Market Size, and Share

Source: Secondary Research, Interviews with Experts, and MarketsandMarkets Analysis

To know about the assumptions considered for the study, Request for Free Sample Report

Medical Polymer Market: Top-Down Approach

Medical  Polymer Market Size, and Share

Source: Secondary Research, Interviews with Experts, and MarketsandMarkets Analysis

Data Triangulation

After arriving at the total market size from the estimation process medical polymer above, the overall market has been split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all the segments and sub-segments, the data triangulation and market breakdown procedures have been employed, wherever applicable. The data has been triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market size has been validated by using both the top-down and bottom-up approaches and primary interviews. Hence, for every data segment, there have been three sources—top-down approach, bottom-up approach, and expert interviews. The data was assumed correct when the values arrived from the three sources matched.

Market Definition

Medical polymers refer to a specialized class of polymers designed and utilized specifically for medical and healthcare applications. These polymers are engineered to meet stringent requirements such as biocompatibility, sterilizability, and chemical resistance, making them suitable for use in medical devices, equipment, implants, and packaging materials. Medical polymers play a crucial role in modern healthcare by providing properties like flexibility, durability, transparency, and ease of processing, which are essential for the development and production of safe and effective medical products. They are used in a wide range of medical applications, including surgical instruments, catheters, implants, drug delivery systems, and diagnostic equipment, contributing significantly to advancements in medical technology and patient care.

Key Stakeholders

  • Medical polymer Manufacturers
  • Medical polymer Traders, Distributors, and Suppliers
  • Raw Type Suppliers
  • Government and Private Research Organizations
  • Associations and Industrial Bodies
  • R&D Institutions
  • Environmental Support Agencies

Report Objectives

  • To define, describe, and forecast the size of the medical polymer market, in terms of value and volume.
  • To provide detailed information regarding the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market.
  • To estimate and forecast the market size based on type, application, manufacturing technology, and region.
  • To forecast the size of the market with respect to major regions, namely, Europe, North America, Asia Pacific, Middle East & Africa, and South America, along with their key countries.
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and their contribution to the overall market.
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape of market leaders.
  • To track and analyze recent developments such as expansions, new product launches, partnerships & agreements, and acquisitions in the market.
  • To strategically profile key market players and comprehensively analyze their core competencies.

Available Customizations

Along with the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

Regional Analysis

  • Further breakdown of a region with respect to a particular country or additional application

Company Information

  • Detailed analysis and profiles of additional market players

Tariff & Regulations

  • Regulations and impact on medical polymer market

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Medical Polymer Market

DMCA.com Protection Status